OpenEvidence

As a part of OpenEvidence’s commitment to creating advanced AI models for medical specialties, the company has extended their oncology model to include the ASCO Guidelines. ASCO Guidelines will now appear within OpenEvidence answers, accompanied by peer-reviewed evidence, precise citations, and a direct link to the ASCO website.

Until now, clinicians using AI tools had to manually pull together the relevant details of a patient’s case. With patient-aware clinical intelligence, OpenEvidence, the most widely used medical AI and clinical decision making tool among U.S. physicians, works directly within Epic to draw on a patient’s full record — medications, allergies, comorbidities, prior procedures, longitudinal data — and interpret the medical literature through the lens of that specific patient.

Cedars-Sinai is the first academic health system to deploy this at enterprise scale via the OpenEvidence x Cedars-Sinai partnership unifying real-time patient context with the world’s leading medical literature to transform point-of-care decision-making

The Society of Surgical Oncology (SSO) and OpenEvidence the most widely used medical knowledge platform announced a strategic partnership to strengthen access to the most trusted surgical oncology evidence at the point of care.

The Global Initiative for Asthma (GINA) collaborates with OpenEvidence to make GINA’s evidence-based asthma strategy reports, clinical recommendations, and educational resources available directly through OpenEvidence.

Another incredible partnership! The American Urological Association and OpenEvidence entered in a partnership that will allow clinicians to surface AUA clinical practice guidelines and consensus statements.

OpenEvidence now integrates National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology directly into answers! This is an incredible collaboration for practicing Hematologists and Oncologists across the country and world that will help clinicians give the best possible care to patients in one of the most challenging and rapidly evolving areas of medicine.

OpenEvidence now integrates National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology! This is a monumental collaboration for practicing Hematologists and Oncologists across the country and world which will help clinicians give the best possible care to patients in one of the most challenging and rapidly evolving areas of medicine.